• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN & SHURTLEFF, INC. / MEDOS S.A. HAKIM PROGRAMMABLE VALVE WIHOUT PRECHAMBER; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN & SHURTLEFF, INC. / MEDOS S.A. HAKIM PROGRAMMABLE VALVE WIHOUT PRECHAMBER; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Catalog Number 82-3101
Device Problems Partial Blockage (1065); Break (1069); Programming Issue (3014)
Patient Problem Edema (1820)
Event Date 01/25/2018
Event Type  Injury  
Manufacturer Narrative
Product made prior to compliance date, gtin unavailable; (b)(4).Upon completion of the investigation a follow up report will be filed.
 
Event Description
The valve was implanted to the patient via vp-shunt on (b)(6) 2017 because the ventricle become to be bigger.Initial setting was unknown.After that, the edema occurred although it was set as low as 70 mmh2o.It was reported that the pressures setting was not able to be changed when the surgeon tried to change the setting.The revision removal surgery was performed on (b)(6) 2018.The surgeon commented that it was suspected the biological component was clogged or the valve was broken.The patient¿s information was not available.No further information was provided by the hospital.The product will be returned to your site.
 
Manufacturer Narrative
The device has been returned for evaluation.Upon completion of the investigation, a follow-up report will be submitted.
 
Manufacturer Narrative
The device was returned for evaluation.The valve was visually inspected; a crack and bump mark in the valve casing was noted and the proximal connector end of the valve was cut off (the connector was not returned).The position of the cam when valve was received was 30mmh2o.The valve was tested for programming and failed the test.The cam mechanism did not move during the programming process.The valve was dismantled and was examined under microscope at appropriate magnification: the cam mechanism was moved slightly.The valve was then re-tested for programming and passed.A crack and a bump mark was noted in the valve casing.Biological debris was found on the cam mechanism.Review of the device history record for the valve confirmed the valve met specification when released to stock.The root cause for the programming problem was like due to biological debris as once the cam was unstuck the valve could be programmed.The root cause for the crack and bump mark in the valve casing was probably due to the valve receiving a hard knock.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HAKIM PROGRAMMABLE VALVE WIHOUT PRECHAMBER
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer (Section D)
CODMAN & SHURTLEFF, INC. / MEDOS S.A.
rue girardet 29
le locle CH 24 00
SZ  CH 2400
MDR Report Key7293781
MDR Text Key100843098
Report Number1226348-2018-10182
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K974739
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/23/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2020
Device Catalogue Number82-3101
Device Lot NumberCTPBCN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/06/2018
Date Manufacturer Received04/19/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-